Halozyme Therapeutics Inc... (HALO)

NASDAQ: HALO · Real-Time Price · USD

60.11

-1.31 (-2.13%)

At close: May 01, 2025, 3:59 PM

60.21

0.17%

After-hours: May 01, 2025, 04:20 PM EDT

Halozyme Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	1.02B	829.25M	660.12M	443.31M	267.59M	195.99M	151.86M	316.61M	146.69M
Cost of Revenue	159.42M	192.36M	139.3M	81.41M	43.37M	45.55M	10.14M	31.15M	33.21M
Gross Profit	855.91M	636.89M	520.81M	361.9M	224.23M	150.45M	141.73M	285.46M	113.48M
Operating Income	551.48M	337.57M	267.53M	275.9M	144.25M	-67.61M	-69.33M	81M	-83.21M
Interest Income	n/a	n/a	15.9M	6.42M	14.95M	7.11M	n/a	n/a	n/a
Pretax Income	557.13M	348.33M	248.92M	248.52M	129.3M	-72.25M	-79.79M	61.61M	-101.86M
Net Income	444.09M	281.59M	202.13M	402.71M	129.09M	-72.24M	-80.33M	62.97M	-103.02M
Selling & General & Admin	154.34M	149.18M	143.53M	50.32M	45.74M	77.25M	60.8M	53.82M	45.85M
Research & Development	79.05M	76.36M	66.61M	35.67M	34.24M	140.8M	150.25M	150.64M	150.84M
Other Expenses	71.05M	73.77M	43.15M	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	304.43M	299.32M	253.28M	86M	79.97M	218.06M	211.06M	204.46M	196.69M
Interest Expense	18.09M	18.76M	16.95M	7.53M	20.38M	11.63M	18.04M	21.98M	19.98M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	463.85M	491.68M	392.58M	167.41M	123.34M	263.6M	221.19M	235.61M	229.9M
Income Tax Expense	113.04M	66.73M	46.79M	-154.19M	217K	-11K	537K	-1.36M	1.16M
Shares Outstanding (Basic)	126.83M	131.93M	136.84M	140.65M	136.21M	144.33M	143.45M	136.42M	127.19M
Shares Outstanding (Diluted)	129.42M	134.2M	140.61M	146.8M	141.46M	144.33M	143.6M	139.07M	127.96M
EPS (Basic)	3.50	2.13	1.48	2.86	0.95	-0.5	-0.56	0.46	-0.81
EPS (Diluted)	3.43	2.10	1.44	2.74	0.91	-0.5	-0.56	0.45	-0.81
EBITDA	656.54M	451.95M	315.51M	259.04M	152.96M	-56.56M	-69.33M	83.16M	-79.47M
EBIT	575.23M	367.09M	265.87M	275.9M	144.25M	-60.62M	-69.33M	81M	-81.88M
Depreciation & Amortization	81.31M	84.86M	49.64M	3M	3.28M	4.07M	2.39M	2.16M	2.41M